Publication: 2900

Publication: 2900

A phase I/II trial adding the poly(ADP-ribose) polymerase (PARP) inhibitor veliparib to induction carboplatin-paclitaxel in patients with locoregionally advanced squamous cell carcinoma of the head and neck (HNSCC) Alliance A091101

DOI

URL

Google Scholar

Citation:: J Clin Oncol vol 36 (15 suppl) 6031

Meeting Instance:: ASCO 2018
Year:: 2018
Type:: Abstract
Sub type:: Poster Discussion
Funding:: NCTN
Endpoint:: Primary
Analysis:: Preliminary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 3382

Program:: OGC
Primary Committee:: Experimental
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882

Corr. Author:
Authors:: Michael J. Jelinek Nathan R. Foster Alex J. Zoroufy Jonas A. DeSouza Gary K. Schwartz Pamela Munster Tanguy Seiwert Everett E. Vokes

Networks:: CA824, IL043, LAPS-IL057, LAPS-MD017, LAPS-MN026, OH029

Study: Alliance-A091101
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 1/2

Keywords: